Cranberry for Prevention of Urinary Tract Infections in Multiple Sclerosis Patients
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Bladder dysfunction occurs at some time in most patients with multiple sclerosis and these
patients are prone to have recurrent urinary tract infections. Cranberry has been
traditionally used for the treatment and prophylaxis of urinary tract infections but there is
no reliable randomized controlled trial demonstrating evidence of cranberry's utility in this
disease. The aim of our study is to assess the efficacy and safety of cranberry in the
prophylaxis of urinary tract infections in patients with multiple sclerosis with a
prospective randomized, double-blind and placebo-controlled clinical trial.
Phase:
Phase 3
Details
Lead Sponsor:
Rennes University Hospital
Collaborators:
Ministry of Health, France Pierre Fabre Laboratories